135 related articles for article (PubMed ID: 19056012)
1. Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury.
Dellinger RP; Vincent JL; Marshall J; Reinhart K
J Crit Care; 2008 Dec; 23(4):493-9. PubMed ID: 19056012
[TBL] [Abstract][Full Text] [Related]
2. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial design and outcomes in patients with severe sepsis.
Opal SM
Shock; 2003 Oct; 20(4):295-302. PubMed ID: 14501941
[TBL] [Abstract][Full Text] [Related]
4. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
6. Multicenter clinical trials in sepsis: understanding the big picture and building a successful operation at your hospital.
Dellinger RP; Schorr C; Trzeciak S
Crit Care Nurs Clin North Am; 2011 Mar; 23(1):215-25. PubMed ID: 21316577
[TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
8. Surgeons: A Future Role in Clinical Trials?
Rusch VW
Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
[TBL] [Abstract][Full Text] [Related]
9. Post hoc analysis of calfactant use in immunocompromised children with acute lung injury: Impact and feasibility of further clinical trials.
Tamburro RF; Thomas NJ; Pon S; Jacobs BR; Dicarlo JV; Markovitz BP; Jefferson LS; Willson DF;
Pediatr Crit Care Med; 2008 Sep; 9(5):459-64. PubMed ID: 18679142
[TBL] [Abstract][Full Text] [Related]
10. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
11. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
12. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
[TBL] [Abstract][Full Text] [Related]
13. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
14. Sex and critical illness.
Fowler RA; Filate W; Hartleib M; Frost DW; Lazongas C; Hladunewich M
Curr Opin Crit Care; 2009 Oct; 15(5):442-9. PubMed ID: 19657274
[TBL] [Abstract][Full Text] [Related]
15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
16. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
17. Improving clinical trial design in acute lung injury.
Wood KA; Huang D; Angus DC
Crit Care Med; 2003 Apr; 31(4 Suppl):S305-11. PubMed ID: 12682457
[TBL] [Abstract][Full Text] [Related]
18. Assessment of toxicity in cooperative oncology clinical trials: the long and short of it.
Gwede CK; Johnson DJ; Daniels SS; Trotti A
J Oncol Manag; 2002; 11(2):15-21. PubMed ID: 11989815
[TBL] [Abstract][Full Text] [Related]
19. Design and analysis issues for economic analysis alongside clinical trials.
Marshall DA; Hux M
Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
[TBL] [Abstract][Full Text] [Related]
20. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
